Paul J Mellett, Enanta Pharmaceuticals Inc's Treasurer and CFO, just received 30,000 options from the company. The strike price of the options received was $31.42, and these expire on November 20, 2025. Mellett now owns at least 30,000 options on the company.
Some additional info was provided as follows:
Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 20, 2015).
The above information was disclosed in a filing to the SEC. To see thi s filing in its entirety, click here.
To receive a free e-mail notification whenever Enanta Pharmaceuticals Inc makes a similar move, sign up!
Other recent filings from the company include the following:
Major owner of Enanta Pharmaceuticals Inc was just granted 23,500 options - Nov. 21, 2017
Enanta Pharmaceuticals Inc's Sr. VP & Chief Medical Officer was just granted 23,500 options - Nov. 21, 2017
Enanta Pharmaceuticals Inc's Senior Vice President was just granted 21,500 options - Nov. 21, 2017
Enanta Pharmaceuticals Inc's Sr. VP & General Counsel was just granted 21,500 options - Nov. 21, 2017
Enanta Pharmaceuticals Inc's Treasurer and CFO was just granted 22,500 options - Nov. 21, 2017